Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D8C1OA
|
|||
| Drug Name |
AC0176
|
|||
| Drug Type |
PROTAC
|
|||
| Indication | Prostate cancer [ICD-11: 2C82.0; ICD-9: 185] | Phase 1 | [1] | |
| Company |
Accutar Biotechnology
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05241613) A Phase I Study to Evaluate Safety, Tolerability, PK, Pharmacodynamics, and Preliminary Anti-Tumor Activity of AC176 in Patients With Metastatic Castration Resistant Prostate Cancer Who Have Progressed on at Least Two Prior Systemic Therapies. U.S.National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of Accutar Biotechnology | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.